tripelennamine has been researched along with Pulmonary Fibrosis in 2 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eyre, P | 1 |
Nymeyer, DH | 1 |
McCraw, BM | 1 |
Deline, TR | 1 |
Szwed, JJ | 1 |
2 other studies available for tripelennamine and Pulmonary Fibrosis
Article | Year |
---|---|
Protection by acetylsalicylic acid and other agents in experimental acute interstitial pneumonia of calves.
Topics: Animals; Ascariasis; Aspirin; Cattle; Cattle Diseases; Histamine; Lung; Meclofenamic Acid; Methyserg | 1976 |
Pulmonary angiothrombosis caused by "blue velvet" addiction.
Topics: Adult; Biopsy; Dyspnea; Humans; Lung; Male; Pulmonary Artery; Pulmonary Fibrosis; Radiography, Thora | 1970 |